Cargando…

Immune Effector Cell Associated Neurotoxicity (ICANS) in Pediatric and Young Adult Patients Following Chimeric Antigen Receptor (CAR) T-Cell Therapy: Can We Optimize Early Diagnosis?

The Cornell Assessment for Pediatric Delirium (CAPD) was first proposed by the Pediatric Acute Lung Injury and Sepsis Investigators Network-Stem Cell Transplantation and Cancer Immunotherapy Subgroup and MD Anderson CARTOX joint working committees, for detection of immune effector cell associated ne...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brown, Brandon Douglas, Tambaro, Francesco Paolo, Kohorst, Mira, Chi, Linda, Mahadeo, Kris Michael, Tewari, Priti, Petropoulos, Demetrios, Slopis, John M., Sadighi, Zsila, Khazal, Sajad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982581/ https://www.ncbi.nlm.nih.gov/pubmed/33763368 http://dx.doi.org/10.3389/fonc.2021.634445

Ejemplares similares

IMMU-07. IMMUNE EFFECTOR CELL ASSOCIATED NEUROTOXICITY (ICANS) AMONG PEDIATRIC AND AYA PATIENTS: MD ANDERSON CANCER CENTER EXPERIENCE
por: Brown, Brandon, et al.
Publicado: (2020)

Transfusion reactions in pediatric and adolescent young adult haematology oncology and immune effector cell patients
por: Kohorst, Mira A., et al.
Publicado: (2020)

Complete remission in refractory acute lymphoblastic leukemia using blinatumomab after failure of response to CD‐19 chimeric antigen receptor T‐cell therapy
por: Tambaro, Francesco Paolo, et al.
Publicado: (2020)

The Evolution of Chimeric Antigen Receptor T-Cell Therapy in Children, Adolescents and Young Adults with Acute Lymphoblastic Leukemia
por: Ragoonanan, Dristhi, et al.
Publicado: (2022)

Chimeric Antigen Receptor, Teamwork, Education, Assessment, and Management (CAR-TEAM): A Simulation-Based Inter-professional Education (IPE) Intervention for Management of CAR Toxicities
por: Harden, Avis, et al.
Publicado: (2020)

Cardiac Relapse of Acute Lymphoblastic Leukemia Following Hematopoietic Stem Cell Transplantation: A Case Report and Review of Literature
por: Sheikh, Irtiza N., et al.
Publicado: (2021)

Post-Transplant Cyclophosphamide after Matched Sibling and Unrelated Donor Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acute Myeloid Leukemia
por: Sheikh, Irtiza N., et al.
Publicado: (2022)

A multicenter study of ICU resource utilization in pediatric, adolescent and young adult patients post CAR-T therapy
por: Ragoonanan, Dristhi, et al.
Publicado: (2022)

Acute seizures and status epilepticus in immune effector cell associated neurotoxicity syndrome (ICANS)
por: Saw, Jacqui-Lyn, et al.
Publicado: (2022)

Single-center experience using anakinra for steroid-refractory immune effector cell-associated neurotoxicity syndrome (ICANS)
por: Wehrli, Marc, et al.
Publicado: (2022)

Characteristics and Outcomes of Children, Adolescents and Young Adults with Relapsed/Refractory Non-Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplant
por: Nieto, Yago, et al.
Publicado: (2023)

Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapy
por: Mahadeo, Kris M., et al.
Publicado: (2018)

P1401: IDENTIFICATION OF BIOMARKERS AND RISK FACTORS FOR IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME (ICANS) IN CD19-DIRECTED CAR T-CELL THERAPY: A RETROSPECTIVE MACHINE LEARNING-BASED ANALYSIS.
por: Gómez-Llobell, Marina, et al.
Publicado: (2023)

ICANS 8
por: Rutherford Appleton Laboratory. Chilton
Publicado: (1985)

ICANS 8
por: Rutherford Appleton Laboratory. Chilton
Publicado: (1985)

ICANS 8
por: Rutherford Appleton Laboratory. Chilton
Publicado: (1985)

Prior COVID-19 infection may increase risk for developing endothelial dysfunction following hematopoietic cell transplantation
por: Ariagno, Sydney, et al.
Publicado: (2023)

How I treat refractory CRS and ICANS after CAR T-cell therapy
por: Jain, Michael D., et al.
Publicado: (2023)

Management of Aggressive Non-Hodgkin Lymphomas in the Pediatric, Adolescent, and Young Adult Population: An Adult vs. Pediatric Perspective
por: Sheikh, Irtiza N., et al.
Publicado: (2022)

Mechanisms of immune effector cell‐associated neurotoxicity syndrome after CAR‐T treatment
por: Gu, Tianning, et al.
Publicado: (2022)

Forecasting immune effector cell-associated neurotoxicity syndrome after chimeric antigen receptor t-cell therapy
por: Amidi, Yalda, et al.
Publicado: (2022)

Immune effector cell associated neurotoxicity syndrome in chimeric antigen receptor-T cell therapy
por: Sterner, Robert C., et al.
Publicado: (2022)

ICANS prophylaxis: potentially transformative but elusive
por: Dowling, Mark R., et al.
Publicado: (2023)

NFB-06. TREATMENT CHALLENGES IN PEDIATRIC GLIOBLASTOMA MULTIFORME WITH CONCURRENT SOMATIC AND GERMLINE NF1 MUTATIONS WITH GERMLINE MISMATCH REPAIR MUTATIONS: TWO UNIQUE CASES
por: Baig, Muhammed, et al.
Publicado: (2020)

Renal Cell Carcinoma Unclassified with Medullary Phenotype in a Patient with Neurofibromatosis Type 2
por: Sarkar, Sanila, et al.
Publicado: (2023)

LGG-44. PROGNOSTIC SIGNIFICANCE OF IMAGING CHARACTERISTICS IN PEDIATRIC LOW GRADE GLIOMAS
por: Baig, Muhammad, et al.
Publicado: (2020)

Therapeutic Potential of TNFα and IL1β Blockade for CRS/ICANS in CAR-T Therapy via Ameliorating Endothelial Activation
por: Chen, Yunshuo, et al.
Publicado: (2021)

International Collaboration on Advanced Neutron Sources ICANS-X
Publicado: (1988)

Chimeric Antigen Receptor (CAR)-Modified Immune Effector Cell Therapy for Acute Myeloid Leukemia (AML)
por: Acharya, Utkarsh H., et al.
Publicado: (2020)

Autologous CD33-CAR-T cells for treatment of relapsed/refractory acute myelogenous leukemia
por: Tambaro, Francesco Paolo, et al.
Publicado: (2021)

Cytokines in CAR T Cell–Associated Neurotoxicity
por: Gust, Juliane, et al.
Publicado: (2020)

Mathematical modelling of ICAN-mediated persistent firing in hippocampal neurons
por: Giovannini, Francesco, et al.
Publicado: (2015)

IPC training in Sierra Leone- ICAN's role in fighting Ebola
por: Mehtar, S, et al.
Publicado: (2015)

The Organ Trail: A Review of Biomarkers of Organ Failure
por: Dao, Long, et al.
Publicado: (2020)

Classical Hodgkin Lymphoma: From Past to Future—A Comprehensive Review of Pathophysiology and Therapeutic Advances
por: Munir, Faryal, et al.
Publicado: (2023)

P1385: DISTINCT RATES OF ICANS BUT SIMILAR CYTOKINE SIGNATURES BETWEEN TWO CD19-CAR T CELL THERAPIES: LISOCABTAGENE MARALEUCEL AND AXICABTAGENE CILOLEUCEL
por: Rasheed, Yusuf, et al.
Publicado: (2023)

IMMU-02. CHIMERIC ANTIGEN RECEPTOR (CAR) T CELL NEUROTOXICITY CORRELATES WITH PRETREATMENT AND ACUTE CSF NEUROFILAMENT LIGHT CHAIN (NFL) LEVELS
por: Gust, Juliane, et al.
Publicado: (2020)

First ICAN SSD survey- what do we have in Africa?
por: Hakizimana, B, et al.
Publicado: (2015)

Effect of the Substitution Position on the Electronic and Solvatochromic Properties of Isocyanoaminonaphthalene (ICAN) Fluorophores
por: Kovács, Sándor Lajos, et al.
Publicado: (2019)

Hypophosphatemia Due to Increased Effector Cell Metabolic Activity Is Associated with Neurotoxicity Symptoms in CD19-Targeted CAR T-cell Therapy
por: Tang, Jack Pengfei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3gc90biik7t18gjbjom6i6tclf